This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Purdue Pharma L.p.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Katarina Hilgier: Innovator in Lymphoma Treatment
Introduction
Katarina Hilgier is a notable inventor based in Zurich, Switzerland. She has made significant contributions to the field of medical treatments, particularly in the area of oncology. Her work focuses on improving therapeutic approaches for lymphoma and T-cell malignant diseases.
Latest Patents
Katarina holds a patent for "Compounds for treating lymphoma or a T-cell malignant disease." This invention relates to the use of tinostamustine in treating these conditions. The innovation aims to minimize side effects associated with tinostamustine by adjusting the dosage based on the patient's platelet count. This tailored approach enhances the safety and efficacy of the treatment.
Career Highlights
Throughout her career, Katarina has worked with reputable companies such as Purdue Pharma L.P. and Mundipharma International Limited. Her experience in these organizations has contributed to her expertise in pharmaceutical development and patient care.
Collaborations
Katarina has collaborated with esteemed colleagues, including Francisco Ibanez Lopez and Thomas Jorg Mehrling. These partnerships have fostered a collaborative environment that promotes innovation in medical research.
Conclusion
Katarina Hilgier's contributions to the treatment of lymphoma highlight her dedication to improving patient outcomes. Her innovative approach to dosage adjustment represents a significant advancement in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile